Form 8-K - Current report:
SEC Accession No. 0000950170-24-002435
Filing Date
2024-01-05
Accepted
2024-01-05 16:00:18
Documents
58
Period of Report
2023-12-31
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K omga-20231231.htm   iXBRL 8-K 63422
2 PRESS RELEASE omga-ex99_1.htm EX-99.1 23050
3 EX-99.2 omga-ex99_2.htm EX-99.2 31113
4 GRAPHIC img221507246_0.jpg GRAPHIC 104407
5 GRAPHIC img221507246_1.jpg GRAPHIC 345797
6 GRAPHIC img221507246_2.jpg GRAPHIC 174915
7 GRAPHIC img221507246_3.jpg GRAPHIC 156699
8 GRAPHIC img221507246_4.jpg GRAPHIC 154908
9 GRAPHIC img221507246_5.jpg GRAPHIC 214408
10 GRAPHIC img221507246_6.jpg GRAPHIC 149114
11 GRAPHIC img221507246_7.jpg GRAPHIC 66404
12 GRAPHIC img221507246_8.jpg GRAPHIC 160787
13 GRAPHIC img221507246_9.jpg GRAPHIC 157041
14 GRAPHIC img221507246_10.jpg GRAPHIC 134221
15 GRAPHIC img221507246_11.jpg GRAPHIC 129211
16 GRAPHIC img221507246_12.jpg GRAPHIC 145212
17 GRAPHIC img221507246_13.jpg GRAPHIC 173507
18 GRAPHIC img221507246_14.jpg GRAPHIC 171361
19 GRAPHIC img221507246_15.jpg GRAPHIC 71666
20 GRAPHIC img221507246_16.jpg GRAPHIC 195472
21 GRAPHIC img221507246_17.jpg GRAPHIC 188537
22 GRAPHIC img221507246_18.jpg GRAPHIC 143149
23 GRAPHIC img221507246_19.jpg GRAPHIC 163990
24 GRAPHIC img221507246_20.jpg GRAPHIC 145993
25 GRAPHIC img221507246_21.jpg GRAPHIC 146459
26 GRAPHIC img221507246_22.jpg GRAPHIC 78091
27 GRAPHIC img221507246_23.jpg GRAPHIC 124309
28 GRAPHIC img221507246_24.jpg GRAPHIC 129678
29 GRAPHIC img221507246_25.jpg GRAPHIC 124608
30 GRAPHIC img221507246_26.jpg GRAPHIC 109813
31 GRAPHIC img221507246_27.jpg GRAPHIC 141668
32 GRAPHIC img221507246_28.jpg GRAPHIC 151205
33 GRAPHIC img221507246_29.jpg GRAPHIC 121506
34 GRAPHIC img221507246_30.jpg GRAPHIC 120581
35 GRAPHIC img221507246_31.jpg GRAPHIC 66144
36 GRAPHIC img221507246_32.jpg GRAPHIC 168620
37 GRAPHIC img221507246_33.jpg GRAPHIC 153094
38 GRAPHIC img221507246_34.jpg GRAPHIC 132758
39 GRAPHIC img221507246_35.jpg GRAPHIC 182945
40 GRAPHIC img221507246_36.jpg GRAPHIC 131013
41 GRAPHIC img221507246_37.jpg GRAPHIC 136463
42 GRAPHIC img221507246_38.jpg GRAPHIC 211156
43 GRAPHIC img221507246_39.jpg GRAPHIC 60270
44 GRAPHIC img221507246_40.jpg GRAPHIC 176436
45 GRAPHIC img221507246_41.jpg GRAPHIC 170603
46 GRAPHIC img221507246_42.jpg GRAPHIC 185337
47 GRAPHIC img221507246_43.jpg GRAPHIC 58668
  Complete submission text file 0000950170-24-002435.txt   9111556

Data Files

Seq Description Document Type Size
48 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT omga-20231231.xsd EX-101.SCH 2479
49 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT omga-20231231_lab.xml EX-101.LAB 15485
50 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT omga-20231231_pre.xml EX-101.PRE 11872
52 EXTRACTED XBRL INSTANCE DOCUMENT omga-20231231_htm.xml XML 4885
Mailing Address 140 FIRST STREET, SUITE 501 CAMBRIDGE MA 02141
Business Address 140 FIRST STREET, SUITE 501 CAMBRIDGE MA 02141 (617) 949-4360
Omega Therapeutics, Inc. (Filer) CIK: 0001850838 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40657 | Film No.: 24516129
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)